[English] 日本語
Yorodumi
- PDB-4wpb: Vascular endothelial growth factor in complex with alpha/beta-VEGF-1 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 4wpb
TitleVascular endothelial growth factor in complex with alpha/beta-VEGF-1
Components
  • Vascular endothelial growth factor A
  • alpha/beta-VEGF-1
KeywordsPROTEIN BINDING / alpha/beta-peptide / foldamer
Function / homology
Function and homology information


basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / cellular stress response to acid chemical / VEGF-A complex / Signaling by VEGF / lymph vessel morphogenesis / positive regulation of lymphangiogenesis / negative regulation of adherens junction organization / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier ...basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / cellular stress response to acid chemical / VEGF-A complex / Signaling by VEGF / lymph vessel morphogenesis / positive regulation of lymphangiogenesis / negative regulation of adherens junction organization / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier / VEGF ligand-receptor interactions / vascular endothelial growth factor receptor binding / positive regulation of mast cell chemotaxis / post-embryonic camera-type eye development / primitive erythrocyte differentiation / positive regulation of protein kinase C signaling / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway / negative regulation of blood-brain barrier permeability / VEGF-activated neuropilin signaling pathway / bone trabecula formation / positive regulation of vascular endothelial growth factor signaling pathway / coronary vein morphogenesis / cardiac vascular smooth muscle cell development / lung vasculature development / lymphangiogenesis / eye photoreceptor cell development / endothelial cell chemotaxis / motor neuron migration / positive regulation of trophoblast cell migration / positive regulation of epithelial tube formation / vascular endothelial growth factor receptor-2 signaling pathway / VEGF binds to VEGFR leading to receptor dimerization / regulation of nitric oxide mediated signal transduction / positive regulation of axon extension involved in axon guidance / vascular wound healing / positive regulation of protein localization to early endosome / regulation of hematopoietic progenitor cell differentiation / positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / positive regulation of branching involved in ureteric bud morphogenesis / camera-type eye morphogenesis / neuropilin binding / induction of positive chemotaxis / coronary artery morphogenesis / negative regulation of cell-cell adhesion mediated by cadherin / vascular endothelial growth factor receptor 2 binding / tube formation / positive regulation of vascular permeability / dopaminergic neuron differentiation / commissural neuron axon guidance / platelet-derived growth factor receptor binding / surfactant homeostasis / negative regulation of epithelial to mesenchymal transition / extracellular matrix binding / cell migration involved in sprouting angiogenesis / cardiac muscle cell development / epithelial cell maturation / sprouting angiogenesis / positive regulation of positive chemotaxis / endothelial cell proliferation / Regulation of gene expression by Hypoxia-inducible Factor / positive regulation of leukocyte migration / vascular endothelial growth factor signaling pathway / positive regulation of p38MAPK cascade / positive regulation of endothelial cell chemotaxis / artery morphogenesis / positive regulation of cell migration involved in sprouting angiogenesis / branching involved in blood vessel morphogenesis / positive regulation of DNA biosynthetic process / retinal ganglion cell axon guidance / positive regulation of neuroblast proliferation / positive chemotaxis / negative regulation of fat cell differentiation / transmembrane receptor protein tyrosine kinase activator activity / positive regulation of sprouting angiogenesis / chemoattractant activity / outflow tract morphogenesis / positive regulation of focal adhesion assembly / mesoderm development / monocyte differentiation / positive regulation of receptor internalization / macrophage differentiation / fibronectin binding / positive regulation of cell division / positive regulation of cell adhesion / neuroblast proliferation / positive regulation of blood vessel endothelial cell migration / cellular response to vascular endothelial growth factor stimulus / mammary gland alveolus development / vasculogenesis / positive regulation of osteoblast differentiation / vascular endothelial growth factor receptor signaling pathway / heart morphogenesis / ovarian follicle development / cell maturation / homeostasis of number of cells within a tissue / positive regulation of protein autophosphorylation / positive regulation of endothelial cell proliferation / epithelial cell differentiation / lactation / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
Similarity search - Function
Vascular endothelial growth factor, heparin-binding domain / Vascular endothelial growth factor, heparin-binding domain superfamily / VEGF heparin-binding domain / : / PDGF/VEGF domain / Platelet-derived growth factor, conserved site / PDGF/VEGF domain / Platelet-derived growth factor (PDGF) family signature. / Platelet-derived growth factor (PDGF) family profile. / Platelet-derived and vascular endothelial growth factors (PDGF, VEGF) family ...Vascular endothelial growth factor, heparin-binding domain / Vascular endothelial growth factor, heparin-binding domain superfamily / VEGF heparin-binding domain / : / PDGF/VEGF domain / Platelet-derived growth factor, conserved site / PDGF/VEGF domain / Platelet-derived growth factor (PDGF) family signature. / Platelet-derived growth factor (PDGF) family profile. / Platelet-derived and vascular endothelial growth factors (PDGF, VEGF) family / Cystine Knot Cytokines, subunit B / Cystine-knot cytokines / Cystine-knot cytokine / Ribbon / Mainly Beta
Similarity search - Domain/homology
Vascular endothelial growth factor A, long form
Similarity search - Component
Biological speciesHomo sapiens (human)
Staphylococcus aureus (bacteria)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 3.11 Å
AuthorsKreitler, D.F. / Checco, J.W. / Gellman, S.H. / Forest, K.T.
Funding support United States, 2items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 GM056414 United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)T32 GM008349 United States
CitationJournal: Proc.Natl.Acad.Sci.USA / Year: 2015
Title: Targeting diverse protein-protein interaction interfaces with alpha / beta-peptides derived from the Z-domain scaffold.
Authors: Checco, J.W. / Kreitler, D.F. / Thomas, N.C. / Belair, D.G. / Rettko, N.J. / Murphy, W.L. / Forest, K.T. / Gellman, S.H.
History
DepositionOct 17, 2014Deposition site: RCSB / Processing site: RCSB
Revision 1.0Apr 15, 2015Provider: repository / Type: Initial release
Revision 1.1Apr 29, 2015Group: Database references
Revision 1.2Sep 20, 2017Group: Author supporting evidence / Database references ...Author supporting evidence / Database references / Derived calculations / Source and taxonomy
Category: citation / entity_src_gen ...citation / entity_src_gen / pdbx_audit_support / pdbx_entity_src_syn / pdbx_struct_oper_list
Item: _citation.journal_id_CSD / _entity_src_gen.pdbx_alt_source_flag ..._citation.journal_id_CSD / _entity_src_gen.pdbx_alt_source_flag / _pdbx_audit_support.funding_organization / _pdbx_entity_src_syn.pdbx_alt_source_flag / _pdbx_struct_oper_list.symmetry_operation
Revision 1.3Oct 11, 2017Group: Data collection / Category: reflns_shell / Item: _reflns_shell.percent_possible_all
Revision 1.4Dec 25, 2019Group: Author supporting evidence / Category: pdbx_audit_support / Item: _pdbx_audit_support.funding_organization
Revision 1.5Dec 27, 2023Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / struct_ncs_dom_lim
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id / _struct_ncs_dom_lim.beg_label_comp_id / _struct_ncs_dom_lim.beg_label_seq_id / _struct_ncs_dom_lim.end_auth_comp_id / _struct_ncs_dom_lim.end_label_asym_id / _struct_ncs_dom_lim.end_label_comp_id / _struct_ncs_dom_lim.end_label_seq_id
Revision 1.6Jul 10, 2024Group: Data collection / Category: chem_comp / Item: _chem_comp.type

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Vascular endothelial growth factor A
B: Vascular endothelial growth factor A
C: alpha/beta-VEGF-1
D: alpha/beta-VEGF-1


Theoretical massNumber of molelcules
Total (without water)33,0844
Polymers33,0844
Non-polymers00
Water00
1


  • Idetical with deposited unit
  • defined by author&software
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area5380 Å2
ΔGint-47 kcal/mol
Surface area13090 Å2
MethodPISA
Unit cell
Length a, b, c (Å)39.100, 78.400, 56.500
Angle α, β, γ (deg.)90.000, 102.800, 90.000
Int Tables number4
Space group name H-MP1211
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
11chain A
21chain B
31chain C
41chain D

NCS domain segments:

Component-ID: 1 / Ens-ID: 1

Dom-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDSelection detailsAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
1GLUGLULYSLYSchain AAA13 - 1076 - 100
2VALVALPROPROchain BBB14 - 1067 - 99
3GLUGLUNH2NH2chain CCC8 - 408 - 40
4GLUGLUNH2NH2chain DDD8 - 408 - 40
Detailsbiological unit is the same as asym.

-
Components

#1: Protein Vascular endothelial growth factor A / VEGF-A / Vascular permeability factor / VPF


Mass: 11948.680 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Details: residues 8-109 / Source: (gene. exp.) Homo sapiens (human) / Gene: VEGFA, VEGF / Plasmid: pET-3d / Production host: Escherichia coli (E. coli) / Strain (production host): BL21(DE3) / References: UniProt: P15692
#2: Protein/peptide alpha/beta-VEGF-1


Mass: 4593.250 Da / Num. of mol.: 2 / Source method: obtained synthetically
Details: This is a synthetic designed molecule based initially on the B domain of Staph aureus protein A.
Source: (synth.) Staphylococcus aureus (bacteria)

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.84 Å3/Da / Density % sol: 56.75 % / Description: crystals were parallelepiped plates
Crystal growTemperature: 298 K / Method: vapor diffusion, hanging drop
Details: 0.1 M magnesium formate dihydrate, 15% (w/v) PEG3350, 30% (v/v) glycerol

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 21-ID-F / Wavelength: 0.97872 Å
DetectorType: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Jun 19, 2014
RadiationMonochromator: C(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97872 Å / Relative weight: 1
ReflectionResolution: 3.1→45.08 Å / Num. obs: 6096 / % possible obs: 99.6 % / Observed criterion σ(I): -3 / Redundancy: 3.7 % / Biso Wilson estimate: 44.01 Å2 / Rmerge F obs: 0.994 / Rmerge(I) obs: 0.083 / Rrim(I) all: 0.097 / Χ2: 0.984 / Net I/σ(I): 14.26 / Num. measured all: 22316
Reflection shell

Diffraction-ID: 1 / Rejects: _

Resolution (Å)Highest resolution (Å)Redundancy (%)Rmerge F obsRmerge(I) obsMean I/σ(I) obsNum. measured obsNum. possibleNum. unique obsRrim(I) all% possible all
3.1-3.183.80.980.2437.4516894434470.283100
3.18-3.270.9810.1978.3117034574520.2398.9
3.27-3.360.990.1669.615714144140.193100
3.36-3.470.9920.1410.4715544124160.164100
3.47-3.580.9940.12111.1815524214150.14198.6
3.58-3.710.9890.12611.8113363673670.148100
3.71-3.850.9920.10612.814043823840.124100
3.85-40.9970.0914.3212823613560.10598.6
4-4.180.9970.0715.2912323423390.08399.1
4.18-4.380.9950.06516.9912463493470.07699.4
4.38-4.620.9960.06118.3410813002990.07199.7
4.62-4.90.9880.06418.6411113043010.07599
4.9-5.240.9970.06119.0110042742740.071100
5.24-5.660.980.06516.8210032772740.07798.9
5.66-6.20.9950.05518.518742372370.064100
6.2-6.930.9980.04719.597642182170.05599.5
6.93-8.010.9960.04420.917061971960.05299.5
8.01-9.80.9960.04521.845711661650.05399.4
9.8-13.870.9950.03922.144341291260.04797.7
13.870.9970.03720.5419973700.04595.9

-
Phasing

PhasingMethod: molecular replacement
Phasing MR
Highest resolutionLowest resolution
Rotation3 Å39.22 Å
Translation3 Å39.22 Å

-
Processing

Software
NameVersionClassification
XDSNovember 11, 2013data reduction
XSCALEJanuary 10, 2014data scaling
PHASER2.5.6phasing
PHENIX1.9-1692refinement
PDB_EXTRACT3.15data extraction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 3.11→45.078 Å / SU ML: 0.41 / Cross valid method: FREE R-VALUE / σ(F): 1.37 / Phase error: 35.03 / Stereochemistry target values: ML
RfactorNum. reflection% reflectionSelection details
Rfree0.2983 506 8.41 %random
Rwork0.2405 5511 --
obs0.2454 6017 99.29 %-
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 112.05 Å2 / Biso mean: 66.8012 Å2 / Biso min: 43.87 Å2
Refinement stepCycle: final / Resolution: 3.11→45.078 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms1909 0 0 0 1909
Num. residues----254
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0251995
X-RAY DIFFRACTIONf_angle_d1.4752682
X-RAY DIFFRACTIONf_chiral_restr0.059295
X-RAY DIFFRACTIONf_plane_restr0.011352
X-RAY DIFFRACTIONf_dihedral_angle_d13.519666
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDRmsType
11A953X-RAY DIFFRACTION11.739TORSIONAL
12B953X-RAY DIFFRACTION11.739TORSIONAL
13C953X-RAY DIFFRACTION11.739TORSIONAL
14D953X-RAY DIFFRACTION11.739TORSIONAL
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.1101-3.4230.36051260.26791366X-RAY DIFFRACTION99
3.423-3.9180.32541250.25841376X-RAY DIFFRACTION100
3.918-4.93530.27421260.22091371X-RAY DIFFRACTION99
4.9353-45.080.27831290.23371398X-RAY DIFFRACTION99
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
12.97521.59761.11024.7537-2.4510.60350.50210.28450.5005-0.08720.2809-0.0986-0.1495-0.0511-0.61341.38530.0240.27590.49150.05760.261317.8996-13.818927.0333
22.40631.5973-2.44261.0858-1.62742.4545-0.24920.60020.4381-0.23010.61450.61-0.9062-1.11-0.39931.6525-0.07380.40130.5730.04120.315210.63645.21984.6995
30.4072-0.41020.10772.97690.16290.0691-0.1951-0.0796-0.11070.47210.1490.46740.2034-0.10860.01521.33040.05920.41690.3466-0.17070.516912.99594.077615.4635
41.6430.7612-0.16114.2027-2.14033.2673-0.26130.02090.0417-0.0577-0.02870.1696-0.0453-0.27020.23620.93970.03640.27080.26550.02340.448813.58568.459910.9411
50.78680.5312-0.32944.1271-1.70781.9651-0.11740.22440.1008-0.73170.0933-0.51710.3877-0.00960.0191.1420.06120.35820.30340.02960.612223.60621.851.8052
60.87290.8132-0.45511.9599-1.11572.9359-0.21840.2869-0.0835-0.08140.04710.09310.0611-0.26880.13971.130.13070.53470.57770.12040.433611.1128-12.440314.9487
71.55410.8640.87699.5531-4.91463.70930.013-0.3717-0.1748-0.30461.03781.06880.5279-0.7583-1.04931.1217-0.31130.20471.13630.12420.54030.3448-21.688521.8339
80.2687-0.28410.05722.13110.23760.052-0.10870.12520.0686-0.50690.09970.5455-0.2241-0.46540.05411.6370.15380.42930.3514-0.18490.306912.442-15.159613.5631
91.41930.07820.35193.4071-2.6425.456-0.13020.15820.145-0.61170.1925-0.0562-0.0414-0.6685-0.13321.05630.02150.11460.3421-0.0140.341311.9538-19.633916.0686
104.00782.6046-2.51446.1665-3.27192.18040.541-0.63030.04691.4596-0.2868-0.1548-0.85510.1766-0.27760.9864-0.07840.03670.57030.05740.343418.218-19.508937.6187
110.02120.2778-0.24327.1292-3.05162.7370.2524-0.2560.48212.1764-0.0220.6385-1.2253-0.3101-0.26261.82710.1878-0.06550.5337-0.08360.71125.3511-14.34941.4365
120.0882-0.04980.31582.71960.06171.1621-0.0195-0.4112-0.01870.7855-0.03390.1717-0.6984-0.1125-0.01141.8491-0.02160.13850.65250.36960.230410.8108-9.135138.8466
131.8126-0.1827-0.84362.3224-0.47350.52740.5908-0.53050.44561.9668-0.3443-0.4703-0.8080.4272-0.20461.9154-0.2145-0.33140.60970.05461.209619.9323-8.62237.1402
142.0001222220.5937-1.7361-1.4224-1.54171.73355.244-0.43160.6305-2.32421.7876-0.1607-0.3021.0496-0.04810.63826.1156-11.486735.4041
150.8932-0.21010.8040.0499-0.19140.7221-0.0107-0.09-0.1309-0.2206-0.1504-0.29640.16990.35430.14060.9479-0.04150.61990.77710.34030.668732.15578.1098-3.4724
160.4584-0.0214-0.26550.5730.22130.2347-0.29460.4288-0.2506-0.3719-0.21260.06050.5078-0.40630.32011.5896-0.03080.6770.4361-0.1450.48822.22933.0769-12.2176
170.81451.1791-0.06534.6757-2.1651.9926-0.0740.2318-0.3957-1.7201-0.07-1.41830.96450.2870.19481.65220.1970.74070.69670.27171.322529.9488-2.6729-4.8045
182.0003222.000122.00011.88641.62917.7844-7.8885-9.4701-3.469-5.2194-2.85487.58810.89430.11280.25050.24910.20411.015835.22261.0298-1.5952
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1chain 'D' and (resid 39 through 39 )D39
2X-RAY DIFFRACTION2chain 'A' and (resid 27 through 50 )A0
3X-RAY DIFFRACTION3chain 'A' and (resid 51 through 84 )A0
4X-RAY DIFFRACTION4chain 'A' and (resid 85 through 107 )A0
5X-RAY DIFFRACTION5chain 'B' and (resid 14 through 26 )B0
6X-RAY DIFFRACTION6chain 'B' and (resid 27 through 38 )B0
7X-RAY DIFFRACTION7chain 'B' and (resid 39 through 45 )B0
8X-RAY DIFFRACTION8chain 'B' and (resid 46 through 84 )B0
9X-RAY DIFFRACTION9chain 'B' and (resid 85 through 106 )B0
10X-RAY DIFFRACTION10chain 'C' and (resid 8 through 20 )C0
11X-RAY DIFFRACTION11chain 'C' and (resid 21 through 25 )C0
12X-RAY DIFFRACTION12chain 'C' and (resid 26 through 31 )C0
13X-RAY DIFFRACTION13chain 'C' and (resid 32 through 38 )C0
14X-RAY DIFFRACTION14chain 'C' and (resid 39 through 39 )C0
15X-RAY DIFFRACTION15chain 'D' and (resid 8 through 14 )D0
16X-RAY DIFFRACTION16chain 'D' and (resid 15 through 31 )D0
17X-RAY DIFFRACTION17chain 'D' and (resid 32 through 38 )D0
18X-RAY DIFFRACTION18chain 'D' and (resid 39 through 39 )D0

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlc1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more